Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromes.
Musto
Pellegrino
P
Unit of Hematology and Stem Cell Transplantation, IRCCS Casa Sollievo della Sofferenza Hospital, 71013 S. Giovanni Rotondo, Italy. p.musto@tin.it
Falcone
Antonietta
A
Sanpaolo
Grazia
G
Bisceglia
Michele
M
Matera
Rosella
R
Carella
Angelo Michele
AM
D000368:Aged; D000369:Aged, 80 and over; D000754:Anemia, Refractory, with Excess of Blasts / Q000097:blood / Q000188:drug therapy* / Q000628:therapy; D001803:Blood Transfusion; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D004921:Erythropoietin / Q000097:blood; D005260:Female; D005319:Fetal Hemoglobin / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D004921:Erythropoietin; D013792:Thalidomide; D005319:Fetal Hemoglobin